CXMT's 472% IPO debut and Morningstar's CNY 16.10 fair-value estimate show why analysts are more divided on this stock than any other in Asia.

Experts say shortages are forcing companies to explore Chinese chip supplies, yet adoption is still likely to be selective and politically contested.

CXMT's 472% IPO debut and Morningstar's CNY 16.10 fair-value estimate show why analysts are more divided on this stock than any other in Asia.